View on market: Volatility Prevails, Market is searching for better value
As traders ignored a hotter-than-expected wholesale inflation report, equity markets in Asia opened higher after U.S. equities rose for a fourth day. Early trading saw gains in Australian, Japanese, and South Korean stocks while futures for the benchmark in Hong Kong increased. After the S&P 500 ended its longest winning streak since August on Wednesday, contracts for American stocks also increased as investors concentrated on less hawkish remarks from Federal Reserve speakers. The yield on the 10-year U.S. bond was 4.56% at the time, and Bitcoin was trading below the 27,000 mark. WTI crude was trading above the $83 level, while Brent crude was trading above $85 a barrel.
Economic Calendar:
- USD : CPI (MoM) (Sep) on 12th Oct, 2023
- USD : Initial Jobless Claims on 12th Oct, 2023
- INR : Manufacturing Output (MoM) (Aug) on 12th Oct, 2023
- INR : CPI (YoY) (Sep) on 12th Oct, 2023
Brokerage Radar:
JEFFERIES ON KFIN TECH: Buy, TP raised to Rs 560; While Asian mkt will be organic, it may explore M&A in western mkt.; Domestic MFs & issuer solutions are growing at steady pace; Raise earnings by 1-2% & see 17% Cagr in profit over FY23-26; cashflows can aid M&A.
GS ON TCS: Buy, TP Rs 4020; Rev growth of -0.1% qoq (constant Fx; +2.8% YoY) below GSe of +1% qoq; 1% qoq decline in headcount suggests weak near term rev outlook; Lower rev est. by up to 1%, with FY24 rev growth of 3.8% (constant Fx; vs 5% earlier)
International Markets
U.S & Europe:
Particulars | 11th October | Chg. | Chg.(%) |
Nasdaq | 13659.68 | 96.83 | 0.71 |
Dow | 33804.87 | 65.57 | 0.19 |
FTSE | 7620.03 | -8.18 | -0.11 |
CAC | 7131.21 | -31.22 | -0.44 |
DAX | 15460.01 | 36.49 | 0.24 |
Dow Fut.* | 33864.41 | 59.54 | 0.18 |
Asian markets:
Particulars | 12th October | Chg. | Chg.(%) |
GIFT Nifty | 19852.00 | -2.00 | -0.01 |
Nikkei | 32323.28 | 386.77 | 1.20 |
Straits Times | 3223.24 | 30.37 | 0.95 |
Hang Seng | 18226.34 | 333.24 | 1.86 |
Shanghai | 3095.26 | 16.30 | 0.53 |
ADR Watch:
Particulars | 11th October | Chg. | Chg.(%) |
Dr. Reddy | 67.39 | 0.63 | 0.94 |
HDFC Bank | 59.09 | 0.07 | 0.11 |
ICICI Bank | 22.78 | -0.14 | -0.61 |
Infosys | 17.62 | -0.23 | -1.29 |
Wipro | 5.03 | 0.13 | 2.55 |
Commodities & Currency:
Particulars | Current Price | Chg.(%) |
USD/INR | 83.16 | -0.18 |
Brent | 85.31 | -0.59 |
Gold | 1890.25 | 0.16 |
Silver | 22.238 | 0.47 |
FIIs & DIIs:
Particulars | 11th October | 10th October |
FIIs | -421.77 | -1005.49 |
DIIs | 1032.02 | 1963.34 |
News Update:
TCS: The IT major’s board approves a buyback of 4.09 crore shares (1.12%) at Rs 4,150 apiece, aggregating to Rs 17,000 crore. An interim dividend of Rs 9 per share was also approved by the board, with Oct. 19 as the record date.
Larsen & Toubro: The company received a Rs 64.98 lakh penalty order from the GST authority for disallowance of the transitional credit claimed.
Maruti Suzuki: The company started exporting the Indian-manufactured off-roader Jimny 5-Door to Latin America, the Middle East, and Africa, among other destinations.
Adani Enterprises: The company raised Rs 700 crore through an allotment of 70,000 NCDs on a private placement basis.
JSW Steel: The company was declared the preferred bidder for the Jaisinghpura Iron Ore North Block in Karnataka with 17.66 million tonnes of reserves.
IndusInd Bank: SBI Mutual Fund gets RBI nod for acquiring up to a 9.99% stake in the company by Oct. 10, 2024.
LTIMindtree: The company initiated the Comprehensive Community Development Programme in Subir Block of Dang District in Gujarat to improve the socioeconomic condition of the region.
Cipla: The pharma major’s manufacturing unit, InvaGen Pharmaceuticals, gets an EIR from the U.S. FDA post-inspection of the Long Island facility as voluntary action indicated.
Vedanta: India Ratings downgraded the long-term bank and debt instruments of the company to ‘IND AA-‘ from ‘IND AA’ while placing them on ‘Rating Watch with Negative Implications’.
Timken India: Jamshedpur Plant’s operations will be trimmed down from Oct. 19–24 due to physical verification of inventory and the Durga Pooja festival.
Aurobindo Pharma: Company unit CuraTeQ Biologics signs a letter of intent with Singapore’s Merck Sharp & Dohme for contract manufacturing operations for biologicals.
RVNL: RVNL emerges as the lowest bidder for the supply, installation, testing and commissioning of tunnel communication systems in Assam. The order is worth Rs 28.73 crore for a period of one year.
Shree Renuka Sugars: Anamika Sugar Mills allots 2.32 crore shares for Rs 109.5 crore via rights issue.
Route Mobile: Company’s Bangladesh subsidiary has partnered with Robi Axiata in Bangladesh as a technical enabler and sales partner for Rich Communication Service Business Messaging.
Source: Moneycontrol, Bloomberg Quint, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
- Reports
- a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
- Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations